Literature DB >> 24066601

[Protective effect of yixinshu capsule on myocardial ischemia reperfusion injury in rats].

Jia-Wen Liu1, Xin-Yi Liu, Jian-He Li, Da-Xiong Xiang, Li-Dan Yi, Xiong-Bin Hu, Zu-Guang Ye.   

Abstract

OBJECTIVE: To observe the protective effect of Yixinshu capsule on myocardial ischemia reperfusion injury (MIRI) in SD rats.
METHOD: Sixty healthy SD rats were randomized into six groups: sham group, MIRI model group, Xinsuning capsule group, low, middle or high dose Yixinshu capsule. Acute MIRI rat models were created by reperfusion for 120 min after anterior interventricular branch of the left coronary artery for 30 min. The serum creatine kinase (CK), lactic dehydrogenase (LDH), aspartate aminotransferase (AST) and malondialdehyde(MDA), blood viscosity, and infarction area of myocardium were determined. RESULT: Yixinshu capsule could reduce serum CK, LDH, AST and LDH activity, improve the blood viscosity, and reduced the myocardial infarct size.
CONCLUSION: Yixinshu capsule can protect against MIRI in rats.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24066601

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  Chinese Patent medicine to treat a 32-year-old man with sinus bradycardia and cardiac sinus arrests: A case report.

Authors:  Dong Yan; Xiang-Ru Xu; Yu-Liang Qian; Hai-Yan Peng; Hui Qian; Bo-Wen Yue; Li-Li Zhao; Zi-Han Zhang; Zhu-Yuan Fang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.